| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |